SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Dr. Reddy’s Laboratories informs about allotment of equity shares

20 Dec 2024 Evaluate

Dr. Reddy’s Laboratories has informed that the Nomination, Governance and Compensation Committee of the Board of Directors of the Company has approved the allotment of 13,080 equity shares of Re.1/- each of the Company, fully paid up, on December 19, 2024, to employees pursuant to exercise of their Stock Options, as per the following details: a) 13,080 equity shares of Re.1/- each pursuant to Dr. Reddy’s Employees Stock Options Scheme, 2002. Further, it has enclosed the details as required under Regulation 10(c) of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.

The above information is a part of company’s filings submitted to BSE.


Dr. Reddys Lab Share Price

1267.80 -1.20 (-0.09%)
18-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1824.00
Dr. Reddys Lab 1267.80
Cipla 1355.80
Zydus Lifesciences 1074.30
Lupin 2327.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: